Soligenix, Inc.

About Soligenix, Inc.

Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.

Products & Services

HyBryte™:Treatment for Cutaneous T-Cell Lymphoma (CTCL), currently in NDA Review stage.

SGX302:Treatment for mild to moderate plaque psoriasis, in development.

RiVax®:Vaccine to prevent ricin poisoning, part of Public Health Solutions, in development.

Specialties

Rare disease treatment Orphan drug development Specialized BioTherapeutics Public Health Solutions Cutaneous T-Cell Lymphoma treatment Psoriasis treatment Oral Mucositis treatment Behçet's Disease treatment Ricin poisoning prevention Thermostable vaccine development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 7500000 MR: - FA: 7.5 million FAN: 7500000	D: 2025-09-29 FD: 2025-09-29	-
2	RT: Public Offering T: - FT: Public Offering	A: 7500000 MR: - FA: 7.5 million FAN: 7500000	D: 2025-09-26 FD: 2025-09-26	1 investors
3	RT: Public Offering T: - FT: Public Offering	A: 4750000 MR: - FA: $4.75 million FAN: 4750000	D: 2024-04-18 FD: 2024-04-18	-
4	RT: Public Offering T: - FT: Public Offering	A: 8500000 MR: - FA: $8.5 million FAN: 8500000	D: 2023-05-09 FD: 2023-05-09	1 investors
5	RT: Public Offering T: - FT: Public Offering	A: 8500000 MR: - FA: 8.5 million FAN: 8500000	D: 2023-05-05 FD: 2023-05-05	-

Public Offering Latest

2025-09-29

$7.5M

Public Offering 2025-09-26

$7.5M

Public Offering 2024-04-18

$4.8M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

N

Neal Bhatia

Dermatologist in private practice and Director of Clinical Dermatology at Therapeutics Clinical Research

G

George Han

Vice President of the Dermatologic Society of Greater New York; Associate Professor in the Department of Dermatology at the Donald and Barbara Zucker School of Medicine at Hofstra / Northwell

J

Jonathan Weiss

Adjunct assistant clinical professor of Dermatology at the Emory University School of Medicine; Dermatologist in private practice at Georgia Dermatology Partners and Gwinnett Clinical Research Center, Inc

P

Paul Yamauchi

Dermatologist in private practice and Medical Director at both the Dermatology Institute & Skin Care Center and Clinical Science Institute in Santa Monica, California. Clinical assistant professor of medicine in the Division of Dermatology at the David Geffen School of Medicine at UCLA and Harbor-UCLA Medical Center

B

Bart Currie

Professor, Menzies School of Health Research and Head of the Royal Darwin Hospital Infectious Diseases Department, Darwin, Northern Territory, Australia

D

David AB Dance

Consultant Microbiologist for the Lao-Oxford-Mahosot-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, UK, and Public Health England

View 31 more team members with Pro

Unlock Full Team Directory

Recent News

Soligenix, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised